SEARAINBOW(SZ:000503) Zhong Guo Zheng Quan Bao·2025-09-18 10:17Core Insights - The company held a performance briefing for the first half of 2025, discussing operational results and future plans, focusing on AI commercialization, digital healthcare, and cost reduction strategies [1] - The company achieved a revenue of 95.53 million yuan in the reporting period, optimizing its business structure and maintaining a leading position in the digital healthcare sector [2] Group 1: Business Performance - In the first half of 2025, the company actively responded to market changes and optimized its business structure, focusing on the integration of healthcare, medical insurance, and pharmaceuticals [1] - The company’s revenue reached 95.53 million yuan, with significant achievements in digital medical insurance, including winning a bid for a drug procurement subsystem project worth 10.66 million yuan [2] - The company holds a market share of 40.5% in payment methods and 17.4% in fund supervision, leading the industry in bid-winning scale [2] Group 2: Strategic Focus - The company is concentrating on four core business areas: comprehensive management of medical insurance funds, medical quality and safety services, drug and device regulation, and innovative health services [1] - In the second half of 2025, the company aims for steady revenue growth and cost reduction, focusing on AI model empowerment, deepening data application, and advancing comprehensive reforms [2] - The company is accelerating its AI transformation in the digital healthcare sector, launching core products like Intelligent Review 2.0 and promoting a smart service ecosystem in disease prevention and control [2]